Innovative Industrial Properties (IIPR) Q3 2025 Earnings
Reported Nov 3, 2025 at 6:26 PM ET · SEC Source
Q3 25 EPS
$0.97
BEAT +7.38%
Est. $0.90
Q3 25 Revenue
$64.7M
BEAT +1.51%
Est. $63.7M
vs S&P Since Q3 25
+22.3%
BEATING MARKET
IIPR +32.7% vs S&P +10.4%
Market Reaction
Did IIPR Beat Earnings? Q3 2025 Results
Innovative Industrial Properties delivered a stronger-than-expected Q3 2025, posting earnings of $0.97 per diluted share against a consensus estimate of $0.90, a 7.38% beat, even as the cannabis-focused REIT navigated a turbulent period for its tenan… Read more Innovative Industrial Properties delivered a stronger-than-expected Q3 2025, posting earnings of $0.97 per diluted share against a consensus estimate of $0.90, a 7.38% beat, even as the cannabis-focused REIT navigated a turbulent period for its tenant base. Revenue came in at $64.69 million, edging past the $63.72 million estimate by 1.51%, though that figure still represented a 15.5% decline year-over-year, driven primarily by a $14.90 million revenue hit from defaults at tenants including PharmaCann, Gold Flora, TILT, and 4Front Ventures. The company's strategic response has been twofold: aggressively pursuing evictions and re-leasing vacated properties on one front, while making its first foray outside cannabis on the other, committing $270 million into IQHQ, a life science real estate platform, at a weighted average interest rate exceeding 14%. The remaining $165 million of that commitment is expected to fund through Q2 2027 and is anticipated to be accretive to AFFO per share, a critical metric given that AFFO already covers a high-yield dividend at an elevated 111% payout ratio.
Key Takeaways
- • $14.9 million revenue decrease due to tenant defaults from PharmaCann, Gold Flora, TILT and 4Front Ventures
- • $1.6 million increase from annual contractual rent escalations
- • $1.6 million increase from new leases on four existing properties
- • $1.4 million increase from properties acquired in 2024 and 2025
- • $2.7 million recognized from MIH Note termination boosting interest and other income
IIPR YoY Financials
Q3 2025 vs Q3 2024, source: SEC Filings
IIPR Revenue by Segment
With YoY comparisons, source: SEC Filings
“We are pleased to have made our first investment outside of the cannabis industry during the third quarter with our $270 million financial investment into IQHQ, marking IIP's return to growth and providing meaningful diversification and accretion for IIP's shareholders.”
— Alan Gold, Q3 2025 Earnings Press Release
IIPR Earnings Trends
IIPR vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
IIPR EPS Trend
Earnings per share: estimate vs actual
IIPR Revenue Trend
Quarterly revenue: estimate vs actual
IIPR Quarterly Results
4 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 MISS | $1.07 | $1.02 | -4.97% | $69.0M | +4.16% |
| Q4 25 BEAT FY | $1.05 | $1.06 | +1.27% | $66.7M | +1.10% |
| FY Full Year | — | $3.93 | — | $266.0M | — |
| Q3 25 BEAT | $0.90 | $0.97 | +7.38% | $64.7M | +1.51% |
| Q2 25 MISS | $0.91 | $0.86 | -5.84% | $62.9M | -1.50% |